Mycobacterium Abscessus Complex Lung Disease

checkorphan

Synonyms

MABC Pulmonary Disease, MABC-PD, Mycobacteroides abscessus Lung Infection, Mycobacterium abscessus Pulmonary Infection, Rapidly Growing Mycobacterial (RGM) Lung Disease , Nontuberculous Mycobacterial (NTM) Lung Disease,

Overview

(M. abscessus) complex is a group of rapidly growing, multi-drug resistant nontuberculous mycobacteria (NTM) commonly found in water, soil, and dust. It is a leading cause of severe, chronic, and treatment-refractory pulmonary disease, particularly in individuals with underlying structural lung diseases like cystic fibrosis or bronchiectasis. Because of its extreme intrinsic resistance to most antibiotics, M. abscessus is considered one of the most challenging infectious diseases to treat, with high rates of recurrence and poor clinical outcomes.

Symptoms

The symptoms of this lung disease are similar to other lung conditions and can be slow to progress, making them difficult to distinguish from chronic infections.
  • Chronic Cough: A persistent cough that lasts for weeks or months, often producing mucus (sputum).
  • Fatigue: Deep or extreme tiredness.
  • Shortness of Breath: Dyspnea, particularly with exertion.
  • Unexplained Weight Loss: Significant or unexpected weight loss.
  • Loss of Appetite: Reduced desire to eat.
  • Fever and Night Sweats: Low-grade fevers and sweating at night.
  • Coughing Up Blood: Known as hemoptysis.
  • Chest Pain: Discomfort or pain in the chest area.
  • Wheezing: A whistling sound when breathing.

Causes

Mycobacterium abscessus complex (MABC) lung disease is caused by a group of rapidly growing, highly drug-resistant bacteria found throughout the environment. These bacteria infect the lungs, often causing chronic infections, primarily in individuals with underlying lung conditions or compromised immune systems.

Prevention

Preventing Mycobacterium abscessus complex (MABC) lung disease involves reducing exposure to these bacteria, which are commonly found in water and soil, and taking precautions for individuals with underlying respiratory conditions. Key preventive measures focus on minimizing aerosol exposure, ensuring proper water hygiene, and managing pre-existing lung diseases, as M. abscessus is notorious for being highly resistant to antibiotics.

Diagnosis

Diagnosing Mycobacterium abscessus complex (MABC) pulmonary disease is complex because the bacteria exist in the environment (water, soil) and can colonize the airways without causing active infection. A diagnosis requires a combination of clinical symptoms, imaging, and microbiology, as outlined in the American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) guidelines.

Prognosis

Mycobacterium abscessus complex (MABC) lung disease carries a guarded or poor prognosis, characterized by high treatment failure rates (often) and high rates of relapse or reinfection. It is one of the most difficult nontuberculous mycobacterial (NTM) infections to treat due to intrinsic resistance to most antibiotics.

Treatment

Mycobacterium abscessus complex (MABC) lung disease is notoriously difficult to treat due to intrinsic resistance to most antibiotics. Treatment involves a long-term, multi-drug approach guided by antibiotic susceptibility testing (DST), usually combining intravenous and oral medications to achieve symptom improvement or culture conversion.